Progress in stenotrophomonas maltophilia
10.3760/cma.j.issn.1673-4408.2012.03.005
- VernacularTitle:嗜麦芽窄食单胞菌感染的研究进展
- Author:
Lili DONG
- Publication Type:Journal Article
- Keywords:
Stenotrophomonas maltophilia;
Infection;
Drug-resistance
- From:
International Journal of Pediatrics
2012;39(3):230-233
- CountryChina
- Language:Chinese
-
Abstract:
Stenotrophomonas maltophilia(SMA) is a emerging opportunistic pathogen that can cause difficult-to-treat infections and exhibits significant degrees of poorly understood multidrug resistance,especially in irnmunocompromised patients.SMA is not an inherent virulent pathogen,but it can colonize in respiratorytract epithelial cells and surfaces of medical devices make it an important colonizer in hospitalized patients.Management of SMA infection is hampered because of its high-level intrinsic resistance to many antibiotics and the increasing occurrence of acquired resistance to the first-line drug such as co-trimoxazole.The prevention and treatment of SMA infection attract more and more attention in recent years.
